Cargando…
Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway
Colorectal cancer (CRC) accounts for about 10% of all annually diagnosed cancers and cancer‐related deaths worldwide. STAT3 plays a vital role in the occurrence and development of tumours. Gracillin has shown a significant antitumour activity in tumours, but its mechanism remains unknown. The human...
Autores principales: | Yang, Lehe, Zhu, Tianru, Ye, Hua, Shen, Yili, Li, Zhiping, Chen, Luye, Wang, Canwei, Chen, Xia, Zhao, Haiyang, Xiang, Youqun, Xiao, Zhongxiang, Zhao, Chengguang, Li, Jifa, Hu, Wanle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812262/ https://www.ncbi.nlm.nih.gov/pubmed/33259114 http://dx.doi.org/10.1111/jcmm.16134 |
Ejemplares similares
-
Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis
por: Zheng, Dandan, et al.
Publicado: (2021) -
L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway
por: Bai, Encheng, et al.
Publicado: (2018) -
Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2019) -
Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway
por: Yang, Lehe, et al.
Publicado: (2020) -
Rhein sensitizes human colorectal cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
por: Zhuang, Yan, et al.
Publicado: (2019)